Diversification of prey capture techniques among the piscivores in Lake Tana's (Ethiopia) Labeobarbus species flock (Cyprinidae)

Lake Tana harbours the only known intact species flock of large cyprinid fishes (15 Labeobarbus spp.). One of the most curious aspects of this species flock is the large number (8) of piscivorous species. Cyprinids are not well designed for piscivory (i.e. small slit-shaped pharyngeal cavity, lack of teeth in the oral jaws, lack of a stomach), which raises the question how well adapted these labeobarbs actually are to function as piscivores? In this study we analyse the kinematics of prey capture (by varied combinations of suction, swimming and jaw protrusion) among Lake Tana's piscivorous labeobarbs. Suction feeding kinematics were similar to values reported for other piscivorous fish species. A detailed analysis of several Labeobarbus species displayed distinct types of techniques (overswimming, velocity/volume suction with jaw protrusion) suited to capture elusive prey in different macro-habitats, Lake Tana's Labeobarbus species evolved a wide range of piscivorous predation techniques, a unique scenario for cyprinid fishes

Eigenvalue asymptotics for weighted Laplace equations on rough Riemannian manifolds with boundary

Our topological setting is a smooth compact manifold of dimension two or higher with smooth boundary. Although this underlying topological structure is smooth, the Riemannian metric tensor is only assumed to be bounded and measurable. This is known as a rough Riemannian manifold. For a large class of boundary conditions we demonstrate a Weyl law for the asymptotics of the eigenvalues of the Laplacian associated to a rough metric. Moreover, we obtain eigenvalue asymptotics for weighted Laplace equations associated to a rough metric. Of particular novelty is that the weight function is not assumed to be of fixed sign, and thus the eigenvalues may be both positive and negative. Key ingredients in the proofs were demonstrated by Birman and Solomjak nearly fifty years ago in their seminal work on eigenvalue asymptotics. In addition to determining the eigenvalue asymptotics in the rough Riemannian manifold setting for weighted Laplace equations, we also wish to promote their achievements which may have further applications to modern problems

Functional link between foraging performance, functional morphology, and diet shift in roach (Rutilus rutilus)

This study explores how feeding performance (size-dependent attack rate) and the diet shift from zooplankton to benthic macroinvertebrates in the fish species roach (Rutilus rutilus L.) is related to changes in functional morphology over ontogeny. The morphological changes included overall body shape and structures of the feeding apparatus. The foraging performance of roach on zooplankton, as a function of size, was hump-shaped with a maximum of ~160 mm, and the diet shift took place around 150 mm. Over ontogeny, roach body shape gradually changed from fusiform into high-bodied. The second principal component (PC2) of the feeding apparatus had a U-shaped relationship with body size, with a minimum at 140-mm total length, which is the inverse of that found for the foraging performance on zooplankton. We suggest that changes of the feeding apparatus affect prey intake during the early zooplanktivorous phases and at the final benthivorous feeding stage, whereas prey retention ability limits the maximum intake rate at a later phase of the zooplanktivorous feeding stage. Our results also suggest the presence of both positive and negative correlations in morphology between the feeding niches, which point to the occurrence of morphological trade-offs within ontogenetic niche

Functional link between foraging performance, functional morphology, and diet shift in roach (Rutilus rutilus)

This study explores how feeding performance (size-dependent attack rate) and the diet shift from zooplankton to benthic macroinvertebrates in the fish species roach (Rutilus rutilus L.) is related to changes in functional morphology over ontogeny. The morphological changes included overall body shape and structures of the feeding apparatus. The foraging performance of roach on zooplankton, as a function of size, was hump-shaped with a maximum of ~160 mm, and the diet shift took place around 150 mm. Over ontogeny, roach body shape gradually changed from fusiform into high-bodied. The second principal component (PC2) of the feeding apparatus had a U-shaped relationship with body size, with a minimum at 140-mm total length, which is the inverse of that found for the foraging performance on zooplankton. We suggest that changes of the feeding apparatus affect prey intake during the early zooplanktivorous phases and at the final benthivorous feeding stage, whereas prey retention ability limits the maximum intake rate at a later phase of the zooplanktivorous feeding stage. Our results also suggest the presence of both positive and negative correlations in morphology between the feeding niches, which point to the occurrence of morphological trade-offs within ontogenetic niche

Diversification of prey capture techniques among the piscivores in Lake Tana's (Ethiopia) Labeobarbus species flock (Cyprinidae)

Lake Tana harbours the only known intact species flock of large cyprinid fishes (15 Labeobarbus spp.). One of the most curious aspects of this species flock is the large number (8) of piscivorous species. Cyprinids are not well designed for piscivory (i.e. small slit-shaped pharyngeal cavity, lack of teeth in the oral jaws, lack of a stomach), which raises the question how well adapted these labeobarbs actually are to function as piscivores? In this study we analyse the kinematics of prey capture (by varied combinations of suction, swimming and jaw protrusion) among Lake Tana's piscivorous labeobarbs. Suction feeding kinematics were similar to values reported for other piscivorous fish species. A detailed analysis of several Labeobarbus species displayed distinct types of techniques (overswimming, velocity/volume suction with jaw protrusion) suited to capture elusive prey in different macro-habitats, Lake Tana's Labeobarbus species evolved a wide range of piscivorous predation techniques, a unique scenario for cyprinid fishes

Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot Study

In this randomized-controlled pilot study, the feasibility and safety of tacrolimus monotherapy in immunologically low-risk kidney transplant recipients was evaluated [NTR4824, www.trialregister.nl]. Low immunological risk was defined as maximal 3 HLA mismatches and the absence of panel reactive antibodies. Six months after transplantation, recipients were randomized if eGFR >30 ml/min, proteinuria <50 mg protein/mmol creatinine, no biopsy-proven rejection after 3 months, and no lymphocyte depleting therapy given. Recipients were randomized to tacrolimus/mycophenolate mofetil (TAC/MMF) or to taper and discontinue MMF at month 9 (TACmono). 79 of the 121 recipients were randomized to either TACmono (n = 38) or TAC/MMF (n = 41). Mean recipient age was 59 years and 59% received a living donor transplant. The median follow-up was 62 months. After randomization, 3 TACmono and 4 TAC/MMF recipients experienced a biopsy-proven rejection. At 5 years follow-up, patient survival was 84% in TACmono versus 76% in TAC/MMF with death-censored graft survival of 97% for both groups and no differences in eGFR and proteinuria. Eleven TACmono recipients had an infectious episode versus 22 TAC/MMF recipients (p < 0.03). Donor-specific anti-HLA antibodies were not detected during follow-up in both groups. Tacrolimus monotherapy in selected immunologically low-risk kidney transplant recipients appears safe and reduces the number of infections

Increasing Kidney-Exchange Options Within the Existing Living Donor Pool With CIAT: A Pilot Implementation Study

Computerized integration of alternative transplantation programs (CIAT) is a kidney-exchange program that allows AB0- and/or HLA-incompatible allocation to difficult-to-match patients, thereby increasing their chances. Altruistic donors make this available for waiting list patients as well. Strict criteria were defined for selected highly-immunized (sHI) and long waiting (LW) candidates. For LW patients AB0i allocation was allowed. sHI patients were given priority and AB0i and/or CDC cross-match negative HLAi allocations were allowed. A local pilot was established between 2017 and 2022. CIAT results were assessed against all other transplant programs available. In the period studied there were 131 incompatible couples; CIAT transplanted the highest number of couples (35%), compared to the other programs. There were 55 sHI patients; CIAT transplanted as many sHI patients as the Acceptable Mismatch program (18%); Other programs contributed less. There were 69 LW patients; 53% received deceased donor transplantations, 20% were transplanted via CIAT. In total, 72 CIAT transplants were performed: 66 compatible, 5 AB0i and 1 both AB0i and HLAi. CIAT increased opportunities for difficult-to-match patients, not by increasing pool size, but through prioritization and allowing AB0i and “low risk” HLAi allocation. CIAT is a powerful addition to the limited number of programs available for difficult-to-match patients

ABO-incompatible kidney transplantation in perspective of deceased donor transplantation and induction strategies: a propensity-matched analysis

Kidney transplant candidates are blood group incompatible with roughly one out of three potential living donors. We compared outcomes after ABO-incompatible (ABOi) kidney transplantation with matched ABO-compatible (ABOc) living and deceased donor transplantation and analyzed different induction regimens. We performed a retrospective study with propensity matching and compared patient and death-censored graft survival after ABOi versus ABOc living donor and deceased donor kidney transplantation in a nationwide registry from 2006 till 2019. 296 ABOi were compared with 1184 center and propensity-matched ABOc living donor and 1184 deceased donor recipients (matching: recipient age, sex, blood group, and PRA). Patient survival was better compared with deceased donor [hazard ratio (HR) for death of HR 0.69 (0.49–0.96)] and non-significantly different from ABOc living donor recipients [HR 1.28 (0.90–1.81)]. Rate of graft failure was higher compared with ABOc living donor transplantation [HR 2.63 (1.72–4.01)]. Rejection occurred in 47% of 140 rituximab versus 22% of 50 rituximab/basiliximab, and 4% of 92 alemtuzumab-treated recipients (P < 0.001). ABOi kidney transplantation is superior to deceased donor transplantation. Rejection rate and graft failure are higher compared with matched ABOc living donor transplantation, underscoring the need for further studies into risk stratification and induction therapy [NTR7587, www.trialregister.nl]

Ellipro scores of donor epitope specific HLA antibodies are not associated with kidney graft survival

In kidney transplantation, donor HLA antibodies are a risk factor for graft loss. Accessibility of donor eplets for HLA antibodies is predicted by the ElliPro score. The clinical usefulness of those scores in relation to transplant outcome is unknown. In a large Dutch kidney transplant cohort, Ellipro scores of pretransplant donor antibodies that can be assigned to known eplets (donor epitope specific HLA antibodies [DESAs]) were compared between early graft failure and long surviving deceased donor transplants. We did not observe a significant Ellipro score difference between the two cohorts, nor significant differences in graft survival between transplants with DESAs having high versus low total Ellipro scores. We conclude that Ellipro scores cannot be used to identify DESAs associated with early versus late kidney graft loss in deceased donor transplants.</p

Determination of the clinical relevance of donor epitope-specific HLA-antibodies in kidney transplantation

In kidney transplantation, survival rates are still partly impaired due to the deleterious effects of donor specific HLA antibodies (DSA). However, not all luminex-defined DSA appear to be clinically relevant. Further analysis of DSA recognizing polymorphic amino acid configurations, called eplets or functional epitopes, might improve the discrimination between clinically relevant vs. irrelevant HLA antibodies. To evaluate which donor epitope-specific HLA antibodies (DESAs) are clinically important in kidney graft survival, relevant and irrelevant DESAs were discerned in a Dutch cohort of 4690 patients using Kaplan–Meier analysis and tested in a cox proportional hazard (CPH) model including nonimmunological variables. Pre-transplant DESAs were detected in 439 patients (9.4%). The presence of certain clinically relevant DESAs was significantly associated with increased risk on graft loss in deceased donor transplantations (p &lt; 0.0001). The antibodies recognized six epitopes of HLA Class I, 3 of HLA-DR, and 1 of HLA-DQ, and most antibodies were directed to HLA-B (47%). Fifty-three patients (69.7%) had DESA against one donor epitope (range 1–5). Long-term graft survival rate in patients with clinically relevant DESA was 32%, rendering DESA a superior parameter to classical DSA (60%). In the CPH model, the hazard ratio (95% CI) of clinically relevant DESAs was 2.45 (1.84–3.25) in deceased donation, and 2.22 (1.25–3.95) in living donation. In conclusion, the developed model shows the deleterious effect of clinically relevant DESAs on graft outcome which outperformed traditional DSA-based risk analysis on antigen level.</p